Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Novel risk genes identified in a genome-wide association study for coronary artery disease in patients with type 1 diabetes

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Estimated GFR (eGFR) loss with glucagon like peptide 1 (GLP1) analogue treatment: Data from Sustain 6 and LEADER

    Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

  2. Relative hypoxia in supine and standing position in type 1 diabetes: Impaired autonomic cardiorespiratory control around the clock?

    Publikation: KonferencebidragKonferenceabstrakt til konferenceForskningpeer review

  3. An echocardiographic substrate for dyspnea identifies high risk patients with type 2 diabetes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Epicardial and pericardial adipose tissues are associated with reduced diastolic and systolic function in type 2 diabetes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Romain Charmet
  • Seamus Duffy
  • Sareh Keshavarzi
  • Beata Gyorgy
  • Michel Marre
  • Peter Rossing
  • Amy Jayne McKnight
  • Alexander P Maxwell
  • Tarun Veer Singh Ahluwalia
  • Andrew D Paterson
  • David-Alexandre Trégouët
  • Samy Hadjadj
Vis graf over relationer

BACKGROUND: Patients with type 1 diabetes are more at risk of coronary artery disease than the general population. Although evidence points to a genetic risk there have been no study investigating genetic risk factors of coronary artery disease specific to individuals with type 1 diabetes. To identify low frequency and common genetic variations associated with coronary artery disease in populations of individuals with type 1 diabetes.

METHODS: A two-stage genome wide association study was conducted. The discovery phase involved the meta-analysis of three genome-wide association cohorts totaling 434 patients with type 1 diabetes and coronary artery disease (cases) and 3123 T1D individuals with no evidence of coronary artery disease (controls). Replication of the top association signals (p < 10-5) was performed in five additional independent cohorts totaling 585 cases and 2612 controls.

RESULTS: One locus (rs115829748, located upstream of the MAP1B gene) reached the statistical threshold of 5 × 10-8 for genome-wide significance but did not replicate. Nevertheless, three single nucleotide polymorphisms provided suggestive evidence for association with coronary artery disease in the combined studies: CDK18 rs138760780 (OR = 2.60 95% confidence interval [1.75-3.85], p = 2.02 × 10-6), FAM189A2 rs12344245 (OR = 1.85 [1.41-2.43], p = 8.52 × 10-6) and PKD1 rs116092985 (OR = 1.53 [1.27-1.85], p = 1.01 × 10-5). In addition, our analyses suggested that genetic variations at the ANKS1A, COL4A2 and APOE loci previously found associated with coronary artery disease in the general population could have stronger effects in patients with type 1 diabetes.

CONCLUSIONS: This study suggests three novel candidate genes for coronary artery disease in the subgroup of patients affected with type 1 diabetes. The detected associations deserve to be definitively validated in additional epidemiological studies.

OriginalsprogEngelsk
TidsskriftCardiovascular Diabetology
Vol/bind17
Udgave nummer1
Sider (fra-til)61
ISSN1475-2840
DOI
StatusUdgivet - 25 apr. 2018

ID: 53785203